Evidence map›Paper›PMID 31506869›Full record

ReviewCurrent treatment options in cardiovascular medicine2019

Clinical Applications of MRA 4D-Flow.

Lilia M Sierra-Galan, Christopher J François

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in cardiovascular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. 4D Flow cardiovascular magnetic resonance consensus statement: 2023 update.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Stent interventions for pulmonary artery stenosis improve bi-ventricular flow efficiency in a swine model.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Article
  9. Article
  10. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.Journal of the American Heart Association · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lilia M Sierra-GalanAmerican British Cowdray Medical Center, 154 Carlos Graef Fernandez Ave. Room 207. Tlaxala, Cuajimalpa, 05300, Mexico City, Mexico. lilisierra@wdevel.net.
Christopher J FrançoisSchool of Medicine and Public Health, University of Wisconsin, 600 Highland Ave, Madison, WI, 53792, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewFour-dimensional (4D)-Flow cardiovascular magnetic resonance (CMR) is three-dimensional, time-resolved, three-directional velocity-encoded magnetic resonance that provides flow velocity data within a volumetric region across the cardiac cycle (CC). The goals of this paper are to review the current clinical applications of this technique; provide an overview of the general physics; discuss key points from the expert consensus document; and present recent advances in the field. The advantages and disadvantages of 4D-Flow CMR in comparison with the standard and gold standard methods are summarized. RECENT

findings4D-Flow CMR offers unique insights into cardiac and circulatory physiology with an ability to quantify advanced hemodynamic parameters in a variety of pathologic entities including aortic and pulmonary artery diseases, valvular heart disease, complex congenital heart disease, and extra-thoracic cardiovascular diseases. Recent large cohort studies highlight how it provides information that has clinical impact beyond a better understanding of the disease and that will permit better and more timely management and prognosis. 4D-Flow CMR provides unique qualitative and quantitative flow dynamics information and its impact on cardiac chambers, vessel walls, and myocardium. As scan acquisition and post-processing of 4D-Flow CMR become faster and simpler, the investigational and clinical opportunities will expand dramatically.

Indexed as

4D4D-FlowAortaBlood flowCMRFlowMagnetic resonanceMRAPhase contrast

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.